Wouters W, De Coster R, van Dun J, Krekels M D, Dillen A, Raeymaekers A, Freyne E, Van Gelder J, Sanz G, Venet M
Department of Endocrinology and Oncology, Janssen Research Foundation, Beerse, Belgium.
J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):1049-54. doi: 10.1016/0960-0760(90)90464-v.
R76713 (6-[(4-chlorophenyl)(1H-1,2,4-triazol-1-yl)methyl]-1-methyl-1H- benzotriazole) is a selective, non-steroidal aromatase inhibitor containing an asymmetric carbon atom. In this paper, we compare the effects of R76713 (racemate) with its enantiomers R83839 (the levo-isomer) and R83842 (the dextro-isomer) on steroid biosynthesis in rat cells in vitro and in the rat in vivo. In rat granulosa cells, aromatase activity was inhibited by 50% at concentrations of 0.93 nM of R76713, 240 nM of R83839 and 0.44 nM of R83842, revealing a 545-fold difference in activity between both enantiomers. Up to 1 microM, none of the compounds had any effect on steroid production in primary cultures of rat testicular cells. Above this concentration all three compounds showed a similar slight inhibition of androgen synthesis with a concomitant increase in the precursor progestins, indicative for some effect on the 17-hydroxylase/17,20-lyase enzyme. In rat adrenal cells none of the compounds showed any effect on corticosterone synthesis. At concentrations above 1 microM there was an increase in the levels of 11-deoxycorticosterone pointing towards an inhibition of the 11-hydroxylase enzyme. This increase was more pronounced for R83839 than for R76713 and R83842. In vivo, in PMSG-primed rats, R83842 reduced plasma estradiol by 50%. 2 h after oral administration of 0.0034 mg/kg, whereas 0.011 mg/kg of R76713 and 0.25 mg/kg of R83839 were needed to obtain the same result. Oral administration of up to 20 mg/kg of the compounds did not significantly affect plasma levels of adrenal steroids in LHRH/ACTH-injected rats. Plasma testosterone was lowered at 10 and 20 mg/kg of R83842 and at the highest dose (20 mg/kg) of R76713 and R83839. In conclusion, the present study shows that the aromatase inhibitory activity of R76713 resides almost exclusively in its dextro-isomer R83842. R83842 exhibits a specificity for aromatase as compared to other enzymes involved in steroid biosynthesis of at least a 1000-fold in vitro as well as in vivo. This confirms the extreme selectivity previously found for the racemate.
R76713(6 - [(4 - 氯苯基)(1H - 1,2,4 - 三唑 - 1 - 基)甲基]-1 - 甲基 - 1H - 苯并三唑)是一种含有不对称碳原子的选择性非甾体芳香化酶抑制剂。在本文中,我们比较了R76713(外消旋体)及其对映体R83839(左旋异构体)和R83842(右旋异构体)在体外大鼠细胞和体内大鼠中对类固醇生物合成的影响。在大鼠颗粒细胞中,浓度为0.93 nM的R76713、240 nM的R83839和0.44 nM的R83842可使芳香化酶活性抑制50%,这表明两种对映体的活性相差545倍。在浓度高达1 microM时,这些化合物对大鼠睾丸细胞原代培养物中的类固醇生成均无影响。高于此浓度时,所有三种化合物均对雄激素合成表现出类似的轻微抑制作用,同时前体孕激素增加,这表明对17 - 羟化酶/17,20 - 裂解酶有一定影响。在大鼠肾上腺细胞中,这些化合物对皮质酮合成均无影响。在浓度高于1 microM时,11 - 脱氧皮质酮水平升高,表明对11 - 羟化酶有抑制作用。R83839的这种升高比R76713和R83842更明显。在体内,在注射PMSG的大鼠中,R83842在口服0.0034 mg/kg后2小时可使血浆雌二醇降低50%,而R76713需要0.011 mg/kg,R83839需要0.25 mg/kg才能达到相同效果。口服高达20 mg/kg的这些化合物对注射LHRH/ACTH的大鼠的肾上腺类固醇血浆水平无显著影响。在R83842剂量为10和20 mg/kg以及R76713和R83839最高剂量(20 mg/kg)时,血浆睾酮降低。总之,本研究表明R76713的芳香化酶抑制活性几乎完全存在于其右旋异构体R83842中。与参与类固醇生物合成的其他酶相比,R83842在体外和体内对芳香化酶的特异性至少高1000倍。这证实了之前在外消旋体中发现的极高选择性。